Atlas Trials

Shanxi Province Cancer Hospital

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Shanxi Province Cancer Hospital

RecordFirmDate
Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib (NCT07486648)Shanxi Province Cancer Hospital2026-05-15
Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma (NCT06637007)Shanxi Province Cancer Hospital2024-08-01
MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy (NCT07489339)Shanxi Province Cancer Hospital2024-07-01
Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer (NCT07646145)Shanxi Province Cancer Hospital2024-04-01
Immune Function of Colorectal Cancer Lymph Nodes (NCT06319404)Shanxi Province Cancer Hospital2024-04-01
A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients (NCT06255704)Shanxi Province Cancer Hospital2024-03-15
Family-Supported Palliative Care in Advanced Lung Cancer (NCT07490639)Shanxi Province Cancer Hospital2024-01-01
A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma (NCT06178601)Shanxi Province Cancer Hospital2023-08-03
Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer (NCT07498972)Shanxi Province Cancer Hospital2023-01-01
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma (NCT04714827)Shanxi Province Cancer Hospital2021-01-22
Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia (NCT04714593)Shanxi Province Cancer Hospital2021-01-15
Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma (NCT04715217)Shanxi Province Cancer Hospital2021-01-04
Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer (NCT03356600)Shanxi Province Cancer Hospital2017-12-01

Track Shanxi Province Cancer Hospital automatically

Every clearance here is in the API, with alerts when new ones post.